<i>Candida auris</i>‒Associated Hospitalizations, United States, 2017–2022
Kaitlin Benedict, Kaitlin Forsberg, Jeremy A.W. Gold, James Baggs, Meghan Lyman
Abstract
Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017-2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings underscore the continued need for public health surveillance and C. auris containment efforts.
Topics & Concepts
Candida aurisMedicineIntensive care medicinePublic healthHealth careEmergency medicineAntifungalPathologyDermatologyEconomicsEconomic growthAntifungal resistance and susceptibilityAntibiotic Use and ResistanceFungal Infections and Studies